DNMT3B and colorectal carcinoma: Interestingly, overexpression of DNMT3B in CRC mice model (Apc Min/+ mice), enhanced the number of colon tumors approximately two folds and increased the average size of colonic microadenomas, whereas DNMT3A had no effect (Linhart et al., 2007).